1 | administered | 21,019 |
2 | dosed | 617 |
3 | administrated | 477 |
4 | dripped | 21 |
5 | administrable | 8 |
6 | perifused | 7 |
7 | 250mg/day | 4 |
8 | administred | 3 |
9 | re-injected | 3 |
10 | -27° | 2 |
11 | actived | 2 |
12 | administed | 2 |
13 | co-administration/febuxostat | 2 |
14 | coapplied | 2 |
15 | included.ia | 2 |
16 | re-intubated | 2 |
17 | sodium/kg | 2 |
18 | £3,320 | 2 |
19 | -1.64‰ | 1 |
20 | -lipoproteins | 1 |
21 | 0.2/patient | 1 |
22 | 0.75+/- | 1 |
23 | 1.0700 | 1 |
24 | 1.6/100,000 | 1 |
25 | 1.64‰ | 1 |
26 | 10.80+/-4.33 | 1 |
27 | 117.74 | 1 |
28 | 2-514 | 1 |
29 | 2.06/patient | 1 |
30 | 21.47‰ | 1 |
31 | 224.71 | 1 |
32 | 250ml/bid/day | 1 |
33 | 2·46 | 1 |
34 | 31-7 | 1 |
35 | 341+/-149 | 1 |
36 | 4.1+/-0.7 | 1 |
37 | 4.30ml/kg | 1 |
38 | 423euro | 1 |
39 | 44.3±25.3 | 1 |
40 | 44μg | 1 |
41 | 489.4 | 1 |
42 | 50.87 | 1 |
43 | 500mg/m2 | 1 |
44 | 5×/or | 1 |
45 | 6,829,999 | 1 |
46 | 6.2+/-3.1 | 1 |
47 | 6.2±2.7 | 1 |
48 | 6.63‰ | 1 |
49 | 68° | 1 |
50 | 69.6+/-12.8 | 1 |
51 | administerrd | 1 |
52 | ameiuri | 1 |
53 | co-ignested | 1 |
54 | co-transplanted | 1 |
55 | euro-9.77 | 1 |
56 | euro6811 | 1 |
57 | gi-yen | 1 |
58 | indrops | 1 |
59 | j01m | 1 |
60 | kdog | 1 |
61 | key-entered | 1 |
62 | l30,352,590 | 1 |
63 | oxobacter | 1 |
64 | q24hr | 1 |
65 | rewetted | 1 |
66 | £-1,551 | 1 |
67 | £13,145 | 1 |
68 | £1600 | 1 |
69 | £1624 | 1 |
70 | £1718 | 1 |
71 | £19,390 | 1 |
72 | £19,835.28 | 1 |
73 | £2,425 | 1 |
74 | £27,195 | 1 |
75 | £28,420 | 1 |
76 | £349 | 1 |
77 | £35,193 | 1 |
78 | £374 | 1 |
79 | £4156 | 1 |
80 | £5098 | 1 |
81 | £5249 | 1 |
82 | £64·10 | 1 |
83 | £7028 | 1 |
84 | £84,029 | 1 |
85 | £93,500 | 1 |
86 | ¥1064 | 1 |
87 | ¥1955 | 1 |
88 | ¥2361 | 1 |
89 | €1,830 | 1 |
90 | €1,961 | 1 |
91 | €199,130 | 1 |
92 | €223 | 1 |
93 | €23,473 | 1 |
94 | €3461 | 1 |
95 | €35,555 | 1 |
96 | €47 | 1 |
97 | €50,012 | 1 |
98 | €59 | 1 |
99 | €641 | 1 |
100 | €8,455 | 1 |
101 | €8481 | 1 |
1 | -1.64‰ | 1 |
2 | -27° | 2 |
3 | -lipoproteins | 1 |
4 | 0.2/patient | 1 |
5 | 0.75+/- | 1 |
6 | 1.0700 | 1 |
7 | 1.6/100,000 | 1 |
8 | 1.64‰ | 1 |
9 | 10.80+/-4.33 | 1 |
10 | 117.74 | 1 |
11 | 2-514 | 1 |
12 | 2.06/patient | 1 |
13 | 21.47‰ | 1 |
14 | 224.71 | 1 |
15 | 250mg/day | 4 |
16 | 250ml/bid/day | 1 |
17 | 2·46 | 1 |
18 | 31-7 | 1 |
19 | 341+/-149 | 1 |
20 | 4.1+/-0.7 | 1 |
21 | 4.30ml/kg | 1 |
22 | 423euro | 1 |
23 | 44.3±25.3 | 1 |
24 | 44μg | 1 |
25 | 489.4 | 1 |
26 | 50.87 | 1 |
27 | 500mg/m2 | 1 |
28 | 5×/or | 1 |
29 | 6,829,999 | 1 |
30 | 6.2+/-3.1 | 1 |
31 | 6.2±2.7 | 1 |
32 | 6.63‰ | 1 |
33 | 68° | 1 |
34 | 69.6+/-12.8 | 1 |
35 | actived | 2 |
36 | administed | 2 |
37 | administered | 21,019 |
38 | administerrd | 1 |
39 | administrable | 8 |
40 | administrated | 477 |
41 | administred | 3 |
42 | ameiuri | 1 |
43 | co-administration/febuxostat | 2 |
44 | co-ignested | 1 |
45 | co-transplanted | 1 |
46 | coapplied | 2 |
47 | dosed | 617 |
48 | dripped | 21 |
49 | euro-9.77 | 1 |
50 | euro6811 | 1 |
51 | gi-yen | 1 |
52 | included.ia | 2 |
53 | indrops | 1 |
54 | j01m | 1 |
55 | kdog | 1 |
56 | key-entered | 1 |
57 | l30,352,590 | 1 |
58 | oxobacter | 1 |
59 | perifused | 7 |
60 | q24hr | 1 |
61 | re-injected | 3 |
62 | re-intubated | 2 |
63 | rewetted | 1 |
64 | sodium/kg | 2 |
65 | £-1,551 | 1 |
66 | £13,145 | 1 |
67 | £1600 | 1 |
68 | £1624 | 1 |
69 | £1718 | 1 |
70 | £19,390 | 1 |
71 | £19,835.28 | 1 |
72 | £2,425 | 1 |
73 | £27,195 | 1 |
74 | £28,420 | 1 |
75 | £3,320 | 2 |
76 | £349 | 1 |
77 | £35,193 | 1 |
78 | £374 | 1 |
79 | £4156 | 1 |
80 | £5098 | 1 |
81 | £5249 | 1 |
82 | £64·10 | 1 |
83 | £7028 | 1 |
84 | £84,029 | 1 |
85 | £93,500 | 1 |
86 | ¥1064 | 1 |
87 | ¥1955 | 1 |
88 | ¥2361 | 1 |
89 | €1,830 | 1 |
90 | €1,961 | 1 |
91 | €199,130 | 1 |
92 | €223 | 1 |
93 | €23,473 | 1 |
94 | €3461 | 1 |
95 | €35,555 | 1 |
96 | €47 | 1 |
97 | €50,012 | 1 |
98 | €59 | 1 |
99 | €641 | 1 |
100 | €8,455 | 1 |
101 | €8481 | 1 |
1 | 0.75+/- | 1 |
2 | 1.6/100,000 | 1 |
3 | £93,500 | 1 |
4 | £1600 | 1 |
5 | 1.0700 | 1 |
6 | £64·10 | 1 |
7 | £3,320 | 2 |
8 | £28,420 | 1 |
9 | €199,130 | 1 |
10 | €1,830 | 1 |
11 | £19,390 | 1 |
12 | l30,352,590 | 1 |
13 | 6.2+/-3.1 | 1 |
14 | euro6811 | 1 |
15 | €641 | 1 |
16 | £-1,551 | 1 |
17 | ¥2361 | 1 |
18 | €3461 | 1 |
19 | €1,961 | 1 |
20 | 224.71 | 1 |
21 | €8481 | 1 |
22 | €50,012 | 1 |
23 | 500mg/m2 | 1 |
24 | 44.3±25.3 | 1 |
25 | €223 | 1 |
26 | 10.80+/-4.33 | 1 |
27 | €23,473 | 1 |
28 | £35,193 | 1 |
29 | 489.4 | 1 |
30 | 2-514 | 1 |
31 | £1624 | 1 |
32 | ¥1064 | 1 |
33 | 117.74 | 1 |
34 | £374 | 1 |
35 | £2,425 | 1 |
36 | £13,145 | 1 |
37 | €8,455 | 1 |
38 | €35,555 | 1 |
39 | ¥1955 | 1 |
40 | £27,195 | 1 |
41 | 2·46 | 1 |
42 | £4156 | 1 |
43 | 31-7 | 1 |
44 | 4.1+/-0.7 | 1 |
45 | 6.2±2.7 | 1 |
46 | €47 | 1 |
47 | euro-9.77 | 1 |
48 | 50.87 | 1 |
49 | 69.6+/-12.8 | 1 |
50 | £1718 | 1 |
51 | £19,835.28 | 1 |
52 | £7028 | 1 |
53 | £5098 | 1 |
54 | £84,029 | 1 |
55 | 341+/-149 | 1 |
56 | £5249 | 1 |
57 | £349 | 1 |
58 | €59 | 1 |
59 | 6,829,999 | 1 |
60 | included.ia | 2 |
61 | coapplied | 2 |
62 | dripped | 21 |
63 | key-entered | 1 |
64 | administered | 21,019 |
65 | administred | 3 |
66 | dosed | 617 |
67 | perifused | 7 |
68 | re-intubated | 2 |
69 | administrated | 477 |
70 | re-injected | 3 |
71 | co-transplanted | 1 |
72 | co-ignested | 1 |
73 | administed | 2 |
74 | rewetted | 1 |
75 | actived | 2 |
76 | administerrd | 1 |
77 | administrable | 8 |
78 | 4.30ml/kg | 1 |
79 | sodium/kg | 2 |
80 | kdog | 1 |
81 | 44μg | 1 |
82 | ameiuri | 1 |
83 | j01m | 1 |
84 | gi-yen | 1 |
85 | 423euro | 1 |
86 | oxobacter | 1 |
87 | q24hr | 1 |
88 | 5×/or | 1 |
89 | -lipoproteins | 1 |
90 | indrops | 1 |
91 | co-administration/febuxostat | 2 |
92 | 0.2/patient | 1 |
93 | 2.06/patient | 1 |
94 | 250ml/bid/day | 1 |
95 | 250mg/day | 4 |
96 | 6.63‰ | 1 |
97 | 1.64‰ | 1 |
98 | -1.64‰ | 1 |
99 | 21.47‰ | 1 |
100 | -27° | 2 |
101 | 68° | 1 |